• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Curetis launches diagnostic cartridge for urinary tract infection

April 20, 2018 By Sarah Faulkner

CuretisCuretis said today that it won CE-IVD marking for its Unyvero cartridge designed to diagnose severe urinary tract infections.

The cartridge covers 103 diagnostic targets and can detect 88 pathogens, according to Curetis, including a multi-drug-resistant pathogenic fungus that is of particular concern to hospitalized patients with compromised immune systems. Unyvero UTI can also detect 15 genetic markers of antibiotic resistances.

The company plans to launch the diagnostic at the European Congress of Clinical Microbiology and Infectious Diseases this week.

In a 443-sample study, the test achieved 95.6% sensitivity and 99.3% specificity. The positive predictive value of the diagnostic was 95.8% and the negative predictive value was 99.2%, Curetis noted.

“This new product further enhances our portfolio of Unyvero cartridges for hospital-acquired infections,” Dr. Achim Plum, Curetis’ chief business officer, said in prepared remarks. “With the launch of Unyvero UTI, clinicians now have access to Unyvero cartridges that cover all primary infections which may lead to sepsis, still the number one cause of morbidity and mortality worldwide and the most significant cause of death in non-coronary intensive care units.”

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.

Filed Under: Diagnostics, Featured, Pharmaceuticals Tagged With: curetis

IN CASE YOU MISSED IT

  • Medtronic to separate Diabetes business unit
  • Tandem Diabetes Care wins CE mark for Mobi insulin pump with Control-IQ+ technology
  • Glooko adds chief strategy officer to chief medical officer’s title
  • Cordis launches 10,000-patient registry for drug-eluting balloon
  • Senseonics opens $50M public offering, $25M private placement with Abbott

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS